3 test combo to treat AD?

Share this article:

Combining diagnostic tests that include imaging and cerebrospinal fluid biomarkers can improve prediction of a patient progressing from mild cognitive impairment to Alzheimer's disease, according to a study published Dec. 11 in Radiology.

Duke Medicine researchers reviewed three tests — magnetic resonance imaging (MRI), fluorine 18 fluorodeoxyglucose positron emission tomography (FDG-PET), and cerebrospinal fluid analysis — to learn whether the trio were more accurate than single tests. The study subjects also were given routine clinical exams.

Share this article:
close

Next Article in News

More in News

CMS expands therapy payment research

The government is expanding its research into alternative therapy payments, to consider more holistic changes to the way Medicare reimburses skilled nursing facilities, the Centers for Medicare & Medicaid Services announced Tuesday.

CDC tightens Ebola guidelines for healthcare workers

The Centers for Disease Control and Prevention has issued more stringent guidelines for how healthcare workers should interact with Ebola patients, following an outcry from nurses and other professionals.

Nonprofit providers face alarming market forces, must rally, LeadingAge chairman says

Nonprofit providers face alarming market forces, must rally, ...

Nonprofit long-term care providers must work together to address alarming trends, or their market share could plummet and the sector as a whole could falter, LeadingAge Chairman David Gehm told ...